Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Parry

Showing results (351-360 of 976) with videos related to

Pageof 98
Sort By:
Mutation Research|August 1, 1997
The application of the 32P-postlabelling assay to aquatic biomonitoringJ S Harvey, B P Lyons, M Waldock, et al.
Mutation Research|January 1, 1982
The UKEMS collaborative genotoxicity trial organisation, selection criteria and preparation of the chemicalsJ Ashby, J M Parry, C F Arlett, et al.
Carcinogenesis|January 1, 1983
N-methyl-N'-nitro-N-nitrosoguanidine induced genetic change during the meiotic cell cycle in Saccharomyces cerevisiae: an absence of S-phase specificityS L Kelly, R S Tippins, J M Parry, et al.
Biochemical Society Transactions|April 1, 1991
The effect of cell volume on the rate of lactate release from rat skeletal muscleS J Bevan, M Parry-Billings, E Opara, et al.
Lancet (London, England)|April 18, 1998
Risk factors for and prevention of sporadic infections with vero cytotoxin (shiga toxin) producing Escherichia coli O157S M Parry, R L Salmon, G A Willshaw, et al.
Gut|April 15, 2003
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusS H Doak, G J S Jenkins, E M Parry, et al.
Blood|January 9, 2007
Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalizationJulie Catusse, Chris M Parry, David R Dewin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 1997
An 11-month-old with anti-glomerular basement membrane diseaseS A Bigler, W M Parry, D S Fitzwater, et al.
Lancet (London, England)|September 1, 1990
Does glutamine contribute to immunosuppression after major burns?M Parry-Billings, J Evans, P C Calder, et al.
British Journal of Anaesthesia|November 27, 2007
Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trialM R Rai, T M Parry, A Dombrovskis, et al.
Pageof 98

Showing results (351-360 of 976) with videos related to

Sort By:
Pageof 98
Mutation Research|August 1, 1997
The application of the 32P-postlabelling assay to aquatic biomonitoringJ S Harvey, B P Lyons, M Waldock, et al.
Mutation Research|January 1, 1982
The UKEMS collaborative genotoxicity trial organisation, selection criteria and preparation of the chemicalsJ Ashby, J M Parry, C F Arlett, et al.
Carcinogenesis|January 1, 1983
N-methyl-N'-nitro-N-nitrosoguanidine induced genetic change during the meiotic cell cycle in Saccharomyces cerevisiae: an absence of S-phase specificityS L Kelly, R S Tippins, J M Parry, et al.
Biochemical Society Transactions|April 1, 1991
The effect of cell volume on the rate of lactate release from rat skeletal muscleS J Bevan, M Parry-Billings, E Opara, et al.
Lancet (London, England)|April 18, 1998
Risk factors for and prevention of sporadic infections with vero cytotoxin (shiga toxin) producing Escherichia coli O157S M Parry, R L Salmon, G A Willshaw, et al.
Gut|April 15, 2003
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusS H Doak, G J S Jenkins, E M Parry, et al.
Blood|January 9, 2007
Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalizationJulie Catusse, Chris M Parry, David R Dewin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 1997
An 11-month-old with anti-glomerular basement membrane diseaseS A Bigler, W M Parry, D S Fitzwater, et al.
Lancet (London, England)|September 1, 1990
Does glutamine contribute to immunosuppression after major burns?M Parry-Billings, J Evans, P C Calder, et al.
British Journal of Anaesthesia|November 27, 2007
Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trialM R Rai, T M Parry, A Dombrovskis, et al.
Pageof 98